This is a study of participants with a diagnosis of migraine who completed another clinical
trial NCT02163993. The participants received either LY2951742 or placebo. This study
NCT02766517 will evaluate how certain biomarkers may be related to the participant's response
in study NCT02163993. The study will last about five days.